Do Concussions Kill Brain Cells? The Neurological Impact

Concussions do kill brain cells, though not in the dramatic, instantaneous way most people imagine. The damage unfolds in stages: a rapid mechanical disruption, followed by a metabolic crisis that can last days to weeks, during which neurons may die through both violent rupture and a slower, programmed self-destruction. A single concussion triggers measurable cell death in the brain’s outer layer and underlying white matter, with peak losses observed around 24 hours after injury. The full neurological impact, though, extends well beyond dead neurons into stretched and malfunctioning nerve fibers, leaky barriers, and inflammation that can linger far longer than symptoms do.

What Happens Inside the Brain at the Moment of Impact

When your head absorbs a blow or a sudden change in momentum, the brain shifts inside the skull. That movement stretches and compresses neural tissue unevenly, and the mechanical force does something surprisingly simple at the cellular level: it temporarily punches holes in cell membranes. This nonspecific increase in membrane permeability allows ions and molecules to flood in and out of cells where they don’t belong. The membranes typically reseal themselves within about ten to fifteen minutes, but by then the damage cascade has already started.¹

That brief window of open membranes sets off what researchers call the neurometabolic cascade. Potassium rushes out of cells while calcium floods in, and the brain dumps large amounts of the excitatory chemical glutamate into the spaces between neurons. All of this triggers frantic activity in the brain’s energy systems as cells try to restore their normal chemical balance. The result is an enormous spike in energy demand at exactly the moment the brain is least equipped to meet it, creating a metabolic crisis.² Alongside these ionic shifts, inflammatory chemicals surge, cerebral blood flow drops, and the architecture of neurons themselves becomes damaged.³

The energy crisis also hammers the brain’s mitochondria, the tiny structures inside cells that generate fuel. When mitochondria malfunction, they produce excess free radicals, which are chemically reactive molecules that attack the fatty membranes of cells, warping the proteins embedded in them and compounding the original injury.⁴ So even after the initial force has come and gone, the brain’s own chemistry keeps doing harm.

How Neurons Die After a Concussion

Cell death after a concussion happens through two distinct routes. The first is necrosis, a chaotic, violent form of death in which cells swell and burst, spilling their contents into surrounding tissue and provoking inflammation. The second is apoptosis, a controlled, programmed process in which the cell essentially dismantles itself from the inside. Both have been documented in animal models of mild brain trauma, and the apoptotic pathway appears to be a major contributor to cell loss in both the brain’s gray matter and the white matter below it.⁵

Research using mild traumatic brain injury models in rats found that significant numbers of cells undergoing apoptosis appeared in the injured cortex and underlying white matter within the first 72 hours, peaking at 24 hours. This wave of programmed cell death was preceded by a drop in a protective protein called Bcl-2 as early as two hours after injury, while the level of a pro-death counterpart remained unchanged. That shift in the ratio between protective and destructive signals appears to tip vulnerable cells toward dying.⁶

The practical takeaway here is that much of the cell death from a concussion is not caused directly by the original blow. It is triggered by the biochemical turmoil that follows. That delayed, secondary phase of damage is why the hours and days after a concussion are so important for recovery, and why returning to activity too soon can be dangerous.

Axonal Damage, the Hidden Injury

Neurons communicate through long, cable-like extensions called axons. These fibers are especially vulnerable to the rotational and shearing forces of a concussion because they stretch across large distances in the brain. Damage to them, broadly called diffuse axonal injury, doesn’t always mean the axon snaps immediately. The spectrum ranges from direct mechanical breaking of the axon’s internal skeleton to subtler problems like disrupted transport of molecules along the fiber, swelling, and degradation of structural proteins.⁷

A 2022 study found that concussion leads to widespread loss of sodium channels along axons and progressive disruption of the nodes of Ranvier, the tiny gaps along a nerve fiber that allow electrical signals to jump quickly from one point to the next. Over a two-week follow-up, researchers observed that these changes appeared near, but separate from, the more classically recognized swollen axonal profiles, suggesting this could represent a previously unrecognized type of axonal pathology.⁸ When axons lose their ability to transmit signals efficiently, the result isn’t just a dead cell; it’s a broken connection. That distinction matters, because symptoms like slowed thinking, brain fog, and difficulty concentrating after a concussion may owe more to damaged wiring than to outright cell death.

Blood Biomarkers That Reveal Hidden Damage

One of the frustrating aspects of concussion has been the difficulty of measuring brain injury objectively. Standard CT scans and MRIs usually look normal after a mild traumatic brain injury.⁹ But blood tests are starting to change that picture. When brain cells and their axons are damaged, certain proteins leak into the bloodstream, and detecting them offers a window into what’s actually happening inside the skull.

Neurofilament light chain is a structural protein found inside axons. Elevated levels of it in the blood correlate with brain atrophy and with imaging measures of axonal injury, making it a promising biomarker for both acute concussion and longer-term effects of repeated head trauma.¹⁰ Another protein, glial fibrillary acidic protein (GFAP), is released by a type of brain support cell called astrocytes when they are injured. A study of athletes found that GFAP levels were significantly elevated in the blood within one hour of a head injury compared to uninjured players, and remained elevated for days afterward. When GFAP and neurofilament light chain were combined, they could distinguish concussed players from controls with high accuracy.¹¹

These biomarkers matter because they confirm that even “mild” brain injuries produce real, measurable cellular damage. They also open the door to tracking recovery over time: if protein levels haven’t returned to baseline, the brain hasn’t finished healing, regardless of whether the person feels fine.

The Blood-Brain Barrier and Its Cascading Consequences

The brain is protected by a tightly regulated barrier between its blood vessels and its tissue. This blood-brain barrier controls what gets in and what stays out. A concussion can disrupt it, and when the barrier becomes leaky, molecules and immune cells that normally stay in the bloodstream can enter brain tissue, where they provoke inflammation and potentially worsen injury. The extent of blood-brain barrier breakdown after a concussion may directly influence how quickly and completely neurons recover.¹²

Barrier disruption also connects head injury to broader bodily effects. Concussion triggers changes along the gut-brain axis, a two-way communication highway between the brain and the digestive system. Brain injury can increase intestinal permeability, shift the composition of gut bacteria, and provoke immune responses that feed back into the brain, amplifying neuroinflammation and potentially prolonging neurodegeneration.¹³ Gut-related immune activation and disrupted nutrient absorption may explain why some concussion patients struggle with fatigue, mood disturbances, and cognitive difficulties that seem disproportionate to the original injury.¹⁴ Gut bacteria changes can, in turn, activate brain immune cells called microglia and astrocytes, contributing further to neuronal damage.¹⁵

Subconcussive Hits Add Up

You don’t need a diagnosed concussion to accumulate brain damage. Subconcussive impacts, hits that don’t produce obvious symptoms, can cause measurable changes in brain health when they pile up over a season or a career in contact sports.¹⁶ A neuroimaging study of college football players found that roughly 44% showed signs of decreased blood-vessel-related brain signals over a single season, even though none had been diagnosed with a concussion. Players who sustained higher-force impacts on a daily basis were more likely to show these changes.¹⁷

The long-term picture is more alarming. In a mouse study, repeated subconcussive and concussive blast exposures both failed to produce spatial memory deficits at four months. But by fourteen months, both groups showed memory impairment and neuron loss in the hippocampus, a brain region critical for forming new memories. The researchers linked this delayed decline to sustained changes in microglia, the brain’s resident immune cells, which over time shifted toward a dysfunctional state that adversely affected neurons and blood vessels.¹⁸ The implication is sobering: damage can be silently progressing for years before symptoms appear.

Why the Developing Brain Faces Different Risks

Children and adolescents are not just small adults when it comes to brain injury. The anatomy, mechanical properties, and injury responses of the developing brain differ meaningfully from those of a fully mature one.¹⁹ Younger brains are still building myelin sheaths around their nerve fibers, still pruning unnecessary connections, and still forming the frontal-lobe circuits that govern judgment and impulse control. A concussion that interrupts those developmental processes may have different consequences than one sustained by a brain that has already finished wiring itself. This is one reason pediatric concussion guidelines tend to be more conservative about return-to-play timelines and cognitive rest.²⁰

Second impact syndrome, though rare, disproportionately affects young athletes. It occurs when someone who still has symptoms from a recent concussion sustains another head injury before the brain has healed. The result can be rapid, catastrophic brain swelling and herniation, sometimes killing an otherwise healthy young person within minutes.²¹ The rarity of the condition doesn’t make it unimportant; it underscores why symptom-free clearance before returning to contact activity is non-negotiable, especially for kids.

When Concussions Lead to Long-Term Neurodegeneration

The link between repeated head trauma and later-life brain disease is now well established. Chronic traumatic encephalopathy, or CTE, is a progressive neurodegenerative condition found in people with histories of repetitive mild traumatic brain injury. It is characterized by the accumulation of a misfolded protein called hyperphosphorylated tau in a distinctive pattern around the blood vessels deep in the brain’s folds.²² CTE shares some features with Alzheimer’s disease, particularly the presence of tau tangles, but the distribution and character of the pathology are distinct enough to classify it as a separate condition.²³

Abnormal tau appears early in the process. Histological studies of human brains from people with mild cognitive impairment, Alzheimer’s, and CTE, as well as people who sustained sport- and military-related head injuries, have found robust signs of a particular form of pathological tau (called cis p-tau) in the early stages of disease.²⁴ This early presence raises the possibility that tau could eventually serve as a warning signal long before a person develops the memory loss and personality changes associated with CTE.

Genetic Factors That Influence Vulnerability

Not everyone who sustains repeated concussions develops CTE or lasting cognitive problems, and genetics appear to play a significant role in that variability. The APOE gene, which codes for a protein involved in cholesterol transport and brain repair, comes in several variants. The ε4 version has long been associated with Alzheimer’s risk, and it also appears to worsen outcomes after head trauma. Among brain bank donors older than 65, carrying the APOE ε4 variant was associated with more than twice the odds of advancing to a higher stage of CTE pathology and with greater accumulation of pathological tau in frontal brain regions.²⁵

Animal research reinforces this finding. Mice engineered to carry the APOE4 variant showed more inflammation, neurodegeneration, programmed cell death, and tau accumulation after repeated mild brain injuries compared with mice carrying the APOE3 variant. The APOE4 mice also had lower levels of brain-derived neurotrophic factor, a protein that supports neuron survival and growth.²⁶ You can’t change your genes, but knowing about APOE status could eventually help clinicians tailor return-to-play protocols or monitoring strategies for athletes and military personnel who are genetically more susceptible to lasting harm.

Can the Brain Grow New Neurons After a Concussion?

The adult brain does have limited capacity to produce new neurons, primarily in a region of the hippocampus called the subgranular zone. After a brain injury, there is a brief spike in this process, almost as if the brain recognizes the damage and tries to compensate. But the burst is short-lived. Research in animal models has shown that the early uptick in new neuron production after a concussion is transient and is followed by a persistent decline in the brain’s ability to generate new neurons compared with uninjured animals of the same age.²⁷

The picture is even more nuanced when you look at what the new cells become. After injury, newly born cells on the side of the brain closest to the damage were less likely to mature into functional neurons and more likely to become astrocytes (support cells) or activated microglia (immune cells). On the injured side, the number of immature neurons dropped by as much as 84% relative to controls.²⁸ So the brain does try to repair itself, but the repair effort is underwhelming and may actually be redirected toward immune and structural tasks at the expense of replacing lost neurons. This helps explain why cognitive recovery after a concussion can stall or remain incomplete, particularly when injuries are repeated before the brain has had a chance to stabilize.

Advanced Imaging Is Catching Up to the Damage

For decades, the “normal-looking” brain scan after a concussion created a credibility gap for patients who felt terrible but were told nothing was wrong. Conventional CT and standard MRI simply aren’t sensitive enough to detect diffuse axonal injury, which is the primary form of brain damage in mild traumatic brain injury.⁹ Newer techniques are changing this. Diffusion tensor imaging, which tracks how water molecules move through white matter tracts, can reveal subtle disruptions in axonal integrity that standard scans miss. In patients with post-concussion symptoms, this method has shown reduced white-matter organization in structures connecting major brain regions, and the degree of disruption correlates with symptom severity.²⁹

Other imaging approaches are also proving useful. Arterial spin labeling MRI, which measures blood flow in the brain without injecting contrast dye, has shown its value across all severities of traumatic brain injury, including mild cases where conventional images look completely normal.³⁰ These tools aren’t yet standard in emergency departments, but their increasing availability in research settings means we’re getting better at matching what the patient experiences with what the brain actually looks like under closer scrutiny.

The Frustrating Search for Neuroprotective Drugs

Given everything we know about the biochemical cascade that kills neurons after a concussion, you might expect that scientists would have found a drug to interrupt it by now. They haven’t. Over the past two decades, numerous agents targeting different stages of the injury cascade have been tested in clinical trials, and none have proven effective at improving neurological outcomes after traumatic brain injury. Compounds that showed promise in early-stage studies have repeatedly failed in larger trials.³¹

Animal research continues to identify intriguing candidates. A melatonin receptor activator called ramelteon reduced early brain damage and long-term behavioral deficits in mice when given on a timed daily schedule after injury. It appeared to work by dialing down oxidative stress and inflammation through a specific cellular defense pathway. But when that pathway was knocked out genetically, the drug lost its protective effects, and these results have not yet been tested in humans.³² For now, the most effective “neuroprotective strategy” remains the simplest and least satisfying one: rest, graduated return to activity, and avoiding a second hit while the brain is still recovering.